...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Different roles of alpha-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats.
【24h】

Different roles of alpha-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats.

机译:α-肾上腺素受体亚型在介导新生大鼠心肌细胞蛋白质合成中的不同作用。

获取原文
获取原文并翻译 | 示例

摘要

Summary 1. Three different alpha(1)-adrenoceptor subtypes, designated alpha(1A), alpha(1B) and alpha(1D), have been cloned and identified pharmacologically in cardiomyocytes. In vitro studies have suggested that alpha(1)-adrenoceptors play an important role in facilitating cardiac hypertrophy. However, it remains controversial as to which subtype of alpha(1)-adrenoceptors is involved in this response. In the present study, we investigated the different role of each alpha(1)-adrenoceptor subtype in mediating cardiomyocyte protein synthesis, which is a most important characteristic of cardiac hypertrophy in cultured neonatal rat cardiomyocytes. 2. Cardiomyocyte hypertrophy was monitored by the following characteristic phenotypic changes: (i) an increase in protein synthesis; (ii) an increase in total protein content; and (iii) an increase in cardiomyocyte size. 3. The role of each alpha(1)-adrenoceptor subtype in mediating cardiomyocyte protein synthesis was investigated by the effect of specific alpha(1)-adrenoceptor subtype-selective antagonists on noradrenaline-induced [(3)H]-leucine incorporation. In addition, pK(B) values for alpha(1)-adrenoceptor subtype-selective antagonists were calculated and compared with the corresponding pK(i) values to further identify their effects. 4. Activation of alpha(1)-adrenoceptors by phenylephrine or noradrenaline in the presence of propranolol significantly increased [(3)H]-leucine incorporation, protein content and cell size. 5. Pre-incubating cardiomyocytes with 5-methyl-urapidil, RS 17053 or WB 4101 significantly inhibited noradrenaline-induced [(3)H]-leucine incorporation. However, there was no effect when cardiomyocytes were pre-incubated with BMY 7378. The correlation coefficients between pK(B) values for alpha(1)-adrenoceptor subtype-selective antagonists and pK(i) values obtained from cloned alpha(1A)-, alpha(1B)- or alpha(1D)-adrenoceptors were 0.92 (P < 0.01), 0.66 (P > 0.05) and 0.24 (P > 0.05), respectively. 6. Our results suggest that the alpha(1)-adrenoceptor is dominantly responsible for adrenergic hypertrophy of cultured cardiomyocytes in neonatal rats. The efficiency in mediating cardiomyocyte protein synthesis is alpha(1A) > alpha(1B) alpha(1D).
机译:总结1.在心肌细胞中已克隆和鉴定了三种不同的alpha(1)-肾上腺素受体亚型,分别命名为alpha(1A),alpha(1B)和alpha(1D)。体外研究表明,α(1)-肾上腺素受体在促进心脏肥大中起重要作用。但是,关于哪种α(1)-肾上腺素能受体参与该反应仍存在争议。在本研究中,我们调查了每种α(1)-肾上腺素受体亚型在介导心肌细胞蛋白质合成中的不同作用,这是培养的新生大鼠心肌细胞中心肌肥大的最重要特征。 2.通过以下特征性表型变化监测心肌肥大:(i)蛋白质合成增加; (ii)总蛋白质含量增加; (iii)心肌细胞大小增加。 3.通过对甲肾上腺素诱导的[(3)H]-亮氨酸掺入的特定α(1)-肾上腺素受体亚型选择性拮抗剂的作用,研究了每种α(1)-肾上腺素受体亚型在介导心肌蛋白合成中的作用。此外,计算了α(1)-肾上腺素受体亚型选择性拮抗剂的pK(B)值​​,并将其与相应的pK(i)值进行比较,以进一步确定其作用。 4.在存在心得安的情况下,苯肾上腺素或去甲肾上腺素对α(1)-肾上腺素受体的激活显着增加了[(3)H]-亮氨酸的掺入,蛋白质含量和细胞大小。 5.用5-甲基-尿嘧啶,RS 17053或WB 4101预孵育心肌细胞可显着抑制去甲肾上腺素诱导的[(3)H]-亮氨酸掺入。但是,将心肌细胞与BMY 7378预温育后没有任何效果。α(1)-肾上腺素受体亚型选择性拮抗剂的pK(B)值​​与从克隆的alpha(1A)-获得的pK(i)值之间的相关系数,alpha(1B)-或alpha(1D)-肾上腺素受体分别为0.92(P <0.01),0.66(P> 0.05)和0.24(P> 0.05)。 6.我们的结果表明,α(1)-肾上腺素受体主要负责新生大鼠培养的心肌细胞的肾上腺素能肥大。介导心肌细胞蛋白质合成的效率为alpha(1A)> alpha(1B) alpha(1D)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号